HDI is part of the Informa Tech Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
As record levels of money pour into gene therapy research, biotechs are under pressure to answer questions on safety, delivery and pipelines. Discover the latest advancements in the field in this Trendline.
Gene therapy is once again at the forefront of biomedical research, catalyzed by advances in safer delivery of genes to cells. Science may also move quickly past gene replacement therapy to gene editing via CRISPR and other methods, an approach in which the unknowns are even greater and clinical results are just beginning to emerge.
INCLUDED IN THIS TRENDLINE
Offered Free by: BioPharma Dive and Catalent
See All Resources from: BioPharma Dive and Catalent